Floatz logo

149 assets in Primary Peritoneal Carcinoma

Therapeutic assets addressing Primary Peritoneal Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
Primary Peritoneal Carcinoma
GOG FoundationP3BBB (77)
Carboplatin
Primary Peritoneal Carcinoma
University of WashingtonP3BBB (76)
Adriamycin
Primary Peritoneal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3BBB (74)
Nogitecan
Primary Peritoneal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3BBB (74)
Pegfilgrastim
Primary Peritoneal Carcinoma
TORL Biotherapeutics, LLCP2/3BBB (73)
Docetaxel
Primary Peritoneal Carcinoma
Genelux CorporationP3BB (70)
Durvalumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2BB (70)
Mirvetuximab Soravtansine
Primary Peritoneal Carcinoma
AbbVieP3BB (70)
Olaparib
Primary Peritoneal Carcinoma
University of Colorado, DenverP3BB (70)
Irinotecan
Primary Peritoneal Carcinoma
Tianjin Medical University Cancer Institute and HospitalP3BB (69)
Fluorouracilum
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P3BB (68)
Atezolizumab
Primary Peritoneal Carcinoma
Ronald BuckanovichP2/3BB (66)
Cyclophosphamide
Primary Peritoneal Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3BB (66)
Letrozole
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.P3BB (66)
Veliparib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2BB (66)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Primary Peritoneal Carcinoma
Mayo ClinicP2BB (65)
Oxaliplatin
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P3BB (65)
Palbociclib
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.P2BB (65)
Pembrolizumab
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP3BB (65)
Cediranib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P3BB (64)
Decitabine
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP2BB (64)
Fulvestrant
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.P2BB (64)
Cabozantinib
Primary Peritoneal Carcinoma
M.D. Anderson Cancer CenterP2B (63)
Imnn-001
Primary Peritoneal Carcinoma
ImunonP3B (63)
Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter
Primary Peritoneal Carcinoma
Mayo ClinicP2B (63)
Fluzoparib
Primary Peritoneal Carcinoma
Guangxi Medical UniversityP3B (62)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (62)
Niraparib
Primary Peritoneal Carcinoma
ImunonP3B (62)
Nivolumab
Primary Peritoneal Carcinoma
Regeneron PharmaceuticalsP3B (62)
Rivoceranib
Primary Peritoneal Carcinoma
Guangxi Medical UniversityP3B (62)
Berzosertib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (60)
ibi354
Primary Peritoneal Carcinoma
Innovent Biologics (Suzhou) Co. Ltd.P3B (60)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cldn6 (Claudin 6, Claudin-6)], Monoclonal Antibody (Ixotatug)
Primary Peritoneal Carcinoma
TORL Biotherapeutics, LLCP2B (60)
Ipilimumab
Primary Peritoneal Carcinoma
M.D. Anderson Cancer CenterP2B (60)
Jskn003
Primary Peritoneal Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., LtdP3B (60)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Primary Peritoneal Carcinoma
City of Hope Medical CenterP2B (60)
Paclitaxel Lipid Suspension
Primary Peritoneal Carcinoma
Jina Pharmaceuticals Inc.P3B (60)
Catequentinib
Primary Peritoneal Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3B (59)
Fludarabine
Primary Peritoneal Carcinoma
Beijing BiotechP2B (59)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Primary Peritoneal Carcinoma
Regeneron PharmaceuticalsP2B (59)
Rucaparib
Primary Peritoneal Carcinoma
Grupo Español de Investigación en Cáncer de OvarioP3B (59)
Cobimetinib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (58)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Primary Peritoneal Carcinoma
Toray Industries, IncP2B (58)
Ipatasertib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (58)
Ribociclib
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.P2B (58)
Adavosertib
Primary Peritoneal Carcinoma
M.D. Anderson Cancer CenterP2B (57)
Navicixizumab
Primary Peritoneal Carcinoma
OncXerna Theraputics, Inc.P3B (57)
Peg-Pei-Cholesterol Lipopolymer
Primary Peritoneal Carcinoma
ImunonP3B (57)
Selumetinib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2B (57)
Abemaciclib
Primary Peritoneal Carcinoma
Avenzo Therapeutics, Inc.P2CCC (55)
Showing 1 to 50 of 149 assets
PreviousPage 1 of 3Next